These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16118084

  • 1. Impressive regression of primary liver cancer after treatment with sirolimus.
    Rizell M, Cahlin C, Friman S, Hafström L, Lönn L, Olausson M, Lindner P.
    Acta Oncol; 2005; 44(5):496. PubMed ID: 16118084
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocellular cancer, transplantation, and sirolimus.
    Wall WJ.
    Liver Transpl; 2004 Oct; 10(10):1312-4. PubMed ID: 15376337
    [No Abstract] [Full Text] [Related]

  • 3. Pilot study: rapamycin in advanced hepatocellular carcinoma.
    Schöniger-Hekele M, Müller C.
    Aliment Pharmacol Ther; 2010 Sep; 32(6):763-8. PubMed ID: 20629977
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
    Kornberg A, Küpper B, Tannapfel A, Thrum K, Wilberg J, Bärthel E, Settmacher U.
    Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
    [No Abstract] [Full Text] [Related]

  • 5. Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
    Subbiah IM, Brown RE, Fallon MB.
    Hepatology; 2010 Oct; 52(4):1524. PubMed ID: 20680964
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC, Wang L, Wu WZ.
    Zhonghua Wai Ke Za Zhi; 2008 Nov 01; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract] [Full Text] [Related]

  • 9. [Autopsy case of liver cancer undetected until the terminal stage].
    Hattori M, Katsuta K, Hozumi M.
    Iryo; 1970 Mar 01; 24(3):249-55. PubMed ID: 4316183
    [No Abstract] [Full Text] [Related]

  • 10. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J.
    Transplant Proc; 2008 Dec 01; 40(10):3548-53. PubMed ID: 19100435
    [Abstract] [Full Text] [Related]

  • 11. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
    Toso C, Meeberg GA, Bigam DL, Oberholzer J, Shapiro AM, Gutfreund K, Ma MM, Mason AL, Wong WW, Bain VG, Kneteman NM.
    Transplantation; 2007 May 15; 83(9):1162-8. PubMed ID: 17496530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation--eighteen months of follow-up: a case report.
    Han YS, Choi DL, Park JB.
    Transplant Proc; 2008 Oct 15; 40(8):2835-6. PubMed ID: 18929876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A, Costa A.
    N Engl J Med; 1996 Nov 07; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.